CSIMarket
 
Biotricity Inc   (BTCY)
Other Ticker:  
 
 

Biotricity Inc Growth Comparisons

Select each growth Category to receive further Information



BTCY Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 12 % 1.72 % 7.29 % 3.85 %
Q / Q Revenue Growth (Q3 MRQ) 2.03 % -0.05 % 2.75 % 0.31 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 18.57 % 3.51 % 5.66 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 2.89 % 0.07 % 1.77 % 1.08 %
Revenue 5 Year Average Growth 95.45 % 2.69 % 7.36 % 7.68 %


BTCY's Growth Comparisons in II. Quarter 2024




Facing 12% year on year sales decrease in the second quarter 2024, to $ 3 millions, Biotricity Inc reported smaller declines than the Medical Equipment & Supplies industry with 1.72%, and less than 7.29% growth in the Healthcare sector. Although Medical Equipment & Supplies industry's Sales gains were softer then 3.85% overall market growth, Biotricity Inc and the Healthcare sector have delivered above average market Sales growth.

Comparing the company's Revenue to the first quarter results, sales were higher by 2.03% . On the yearly basis, average annual sales growth for Biotricity Inc is 95.45%, while S & P 500's including only Businesses with the second quarter 2024 earnings, average annual sales growth is 7.68% over the past five years.

BTCY Growth Rates by Company's Segments

Segment Name
Y / Y
Seq.
Technology Fees
12.2 %
1.61 %
Device Sales
26.4 %
8.92 %
Total
-
2.03 %


Growth Rates of BTCY's Income in the second quarter 2024


BTCY Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - 185.83 % 80.17 % 4.2 %
Seq. Operating Income Change (Q3 MRQ) - 27.37 % 33.25 % -2.5 %
Y / Y Operating Income Growth (Q3 TTM) - 234.88 % -5.97 % 9.01 %
Seq. Operating Income Growth (Q3 TTM) - 24.18 % 20.01 % 1.35 %
Operating Income 5 Year Avg. Change - 1.39 % 3.64 % 10.89 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - 355.39 % 288.36 % -1.77 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - 42.24 % 119.49 % -8.86 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - 495.22 % 24.83 % 8.52 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - 33.48 % 57.04 % -0.09 %
Income from Cont. Ops. 5 Year Avg. Change - 1.96 % 2.55 % 11.51 %

BTCY Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - 133 % 7.92 % -6.46 %
Q / Q Net Income Growth (Q3 MRQ) - 90.79 % 133.12 % -6.89 %
Y / Y Net Income Change (Q3 TTM) - 287.65 % -11.98 % 4.97 %
Seq. Net Income Change (Q3 TTM) - 30.07 % 2.61 % -1.42 %
Net Income 5 Year Avg. Growth - 1.83 % 2.41 % 11.48 %

BTCY's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - 597 % 288.36 % -1.77 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - 53.46 % 119.49 % -8.86 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) - - - -6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth - -2.18 % 2.55 % 11.51 %



BTCY EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - 256.63 % 7.92 % -6.46 %
Q / Q EPS Net Growth (Q3 MRQ) - 105.84 % 133.12 % -6.89 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 44.84 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) - - - -6.16 %
EPS Net 5 Year Avg. Change - 1.83 % 2.41 % 11.48 %



Biotricity Inc reported bottom-line of $ -0.07 in the second quarter, compare to $ -0.07 in the same quarter a year ago. Medical Equipment & Supplies industry grew by 256.63%, while Healthcare sector increased by 7.92%, and overall market declined by -6.46%.

Comparing company's EPS to the first quarter results, income per share were higher by 2.03% . On the yearly basis, average annual income per share growth for Biotricity Inc is 95.45%, while S & P 500's including only the businesses with the second quarter 2024 Results, average annual income per share growth is 11.48% over the past five years.

BTCY Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - -21.16 % 37.78 % -42.02 %
Seq. Free Cash Flow Change (Q3 MRQ) - -13.88 % 107.53 % -35.84 %
Y / Y Free Cash Flow Change (Q3 TTM) - -0.76 % 4.58 % 3.33 %
Seq. Free Cash Flow Change (Q3 TTM) - -5.69 % 8.1 % -10.66 %
Free Cash Flow 5 Year Avg. Change - -5.41 % 7.19 % 12.69 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - -79.97 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - -82.34 % - -
Seq. Net Cash Flow Change (Q3 TTM) - -92.71 % - -
Net Cash Flow 5 Year Avg. Change - - 35.57 % 7.68 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) - -7.78 % 1.53 % 2.69 %
Seq. Capital Expenditures Change (Q3 MRQ) - 1.35 % 5.37 % 3.24 %
Y / Y Capital Expenditures Change (Q3 TTM) - -1.28 % 3.86 % 68.3 %
Seq. Capital Expenditures Change (Q3 TTM) - -2.57 % 1.87 % -0.53 %
Capital Expenditures 5 Year Avg. Change - 3.57 % 8.22 % 10.93 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com